Clinical Trials

Title   A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency
Description   The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo, in the treatment of participants in heart failure with iron deficiency and with a reduced ejection fraction.
IRB Number   1095577-2
Treatment   Anemia - Iron deficiency
Status   Active
Start Date   07/21/2017
Principal Name   Christopher Malozzi, DO
Contact Name   Cherie Revere

Email Newsletters

Connect With Us